Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-03-11

FDA Approved: IRBESARTAN — Supplemental Application (NorthStar RxLLC)

View source ↗

Summary

FDA approved a supplemental application for IRBESARTAN submitted by NorthStar RxLLC under an ANDA. The approval pertains to the supplemental filing for the gene…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Irbesartan (irbesartan)

Snippet

SUPPL AP for IRBESARTAN (IRBESARTAN)